About Rhenovia Pharma
Rhenovia Pharma is a company based in Mulhouse (France) founded in 2007.. Rhenovia Pharma has raised $728 thousand across 2 funding rounds from investors including European Union. Rhenovia Pharma offers products and services including Blog Articles and Contact Form. Rhenovia Pharma operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Mulhouse, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$728 K (USD)
in 2 rounds
-
Latest Funding Round
$728 K (USD), Series B
Feb 12, 2014
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rhenovia Pharma
Rhenovia Pharma offers a comprehensive portfolio of products and services, including Blog Articles and Contact Form. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Educational posts on health and beauty for public awareness
Tool for user inquiries and feedback submissions
Funding Insights of Rhenovia Pharma
Rhenovia Pharma has successfully raised a total of $728K across 2 strategic funding rounds. The most recent funding activity was a Series B round of $728 thousand completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $728,000
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2014 | Amount | Series B - Rhenovia Pharma | Valuation |
investors |
|
| Jan, 2013 | Amount | Grant - Rhenovia Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rhenovia Pharma
Rhenovia Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rhenovia Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rhenovia Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rhenovia Pharma Comparisons
Competitors of Rhenovia Pharma
Rhenovia Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rhenovia Pharma
When was Rhenovia Pharma founded?
Rhenovia Pharma was founded in 2007 and raised its 1st funding round 6 years after it was founded.
Where is Rhenovia Pharma located?
Rhenovia Pharma is headquartered in Mulhouse, France. It is registered at Mulhouse, Grand Est, France.
Is Rhenovia Pharma a funded company?
Rhenovia Pharma is a funded company, having raised a total of $728K across 2 funding rounds to date.
What does Rhenovia Pharma do?
Founded in 2007 and based in Mulhouse, France, Rhenovia Pharma operates in the biopharmaceutical sector with a focus on biosimulation for nervous system drug discovery and development. Technologies are applied to model synaptic transmission, including excitatory and inhibitory processes, for diseases like Alzheimers, depression, schizophrenia, epilepsy, stroke, Parkinsons, and rare conditions such as Huntingtons. The RHENOMS platform simulates cognitive deficits and pathologies involving GLUGABA homeostasis, Ca2 regulation, and acetylcholine deregulation.
Who are the top competitors of Rhenovia Pharma?
Rhenovia Pharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Rhenovia Pharma offer?
Rhenovia Pharma offers Blog Articles and Contact Form.
Who are Rhenovia Pharma's investors?
Rhenovia Pharma has 1 investor. Key investors include European Union.